Orserdu combined with Afinitor or Verzenio shows favorable tolerability and progression-free survival in ER-positive, ...

CURE spoke with Patricia I. Moreno, who holds a Ph.D. and is a licensed clinical psychologist and lead of evidence-based ...

BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, ...

Balanced nutrition, emphasizing complex carbohydrates, fiber, and reduced added sugars, plays a critical role in breast ...

The 2025 American Society of Hematology Annual Meeting in December in Orlando, Florida was filled with momentum, discovery ...

The HealthWell Foundation funded Brukinsa (zanubrutinib) for Mike, enabling him to afford the treatment and maintain his ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

A cancer diagnosis profoundly alters family dynamics, emphasizing the importance of cherishing present moments and creating ...

Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...

Cognitive dysfunction in kidney cancer survivors is linked to treatment burden, stress, and fatigue, affecting daily ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...